Search
for
Sort by
Research 421–450 of 1000+
- Cutaneous drug reactions
- Wound healing
- Penatalaksanaan Alopecia Areata (Treatment of Allopecia Areata)
- Developmentally programmed early-age skin localization of iNKT cells supports local tissue development and homeostasis
- Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
- Efficacy of topical calcipotriol betamethasone dipropionate as a new adjuvant therapy to follicular unit extraction technique in treatment of stable vitiligo: clinical, dermoscopic and immunohistological study
- Whole exome sequencing in Alopecia Areata identifies rare variants in KRT82
- 097 LFA-1 blockade prevents the onset of alopecia areata in C3H/HeJ mice
- ROS-responsive hydrogel-delivered miR-665 targets STAT3 to alleviate inflammation and promote hair follicle regeneration in alopecia areata
- ROS-responsive hydrogel-delivered miR-665 targets STAT3 to alleviate inflammation and promote hair follicle regeneration in alopecia areata
- Developing Human Skin Contains Lymphocytes Demonstrating a Memory Signature
- Revealing biological mechanisms of skin pigment recovery during treatment in vitiligo patients: A proteomic analysis
- A preview of selected articles
- Recent Advances in the Pathogenesis of Autoimmune Hair Loss Disease Alopecia Areata
- Alopecia Diffusa while Using Interleukin-17 Inhibitors against Psoriasis Vulgaris
- Chronic delayed-type hypersensitivity reaction as a means to treat alopecia areata
- Major Differences in Expression of Inflammatory Pathways in Skin from Different Body Sites of Healthy Individuals
- A case report of alopecia totalis associated with permanent hair dye use
- Novel potential therapeutic targets of alopecia areata
- Selective blockade of γc pathway ameliorates alopecia areata in a humanized murine model
- Angelica sinensis promotes cortical regeneration of the thymus in mice with acute thymic involution induced by short-term rapamycin treatment
- 27 Preclinical ex vivo and in vivo evidence supporting selective inhibition of tyrosine kinase 2-dependent, IL-12-mediated signaling as a novel pharmacological strategy for alopecia areata management
- 183 PD-1 regulatory network is upregulated in contact immunotherapy during alopecia areata treatment
- 098 Simvastatin decreases AA-associated inflammation through effects on isoprenoid metabolites
- 307 Computer-assisted epitope prediction revealed potential autoantigens associated with human alopecia areata
- Patients with Compound Heterozygous Mutations in Forkhead Box N1 have a Severe Immunodeficiency while Maintaining Normal Skin and Hair Development
- FDA approval of Deuruxolitinib: A New Treatment Option for Severe Alopecia Areata
- Is female-pattern hair loss an autoimmune-like disorder? Unveiling the “silent” inflammation
- LB708 ILC1-like innate lymphocytes in human autoimmunity: Lessons from Alopecia Areata
- Mucin‐poor follicular mycosis fungoides